These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29916919)
21. Incidental detection by Mangas Losada M; García Megías I; Boulvard Chollet X; Romero Robles L; Garrastachu Zumarán P; Ramírez Lasanta R Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):115-116. PubMed ID: 38331247 [No Abstract] [Full Text] [Related]
22. FDG PET/CT of Hepatoid Adenocarcinoma of the Gallbladder. Ji X; Dong H; Dong A Clin Nucl Med; 2020 Nov; 45(11):927-928. PubMed ID: 32910054 [TBL] [Abstract][Full Text] [Related]
23. Cervical and uterine metastasis from carcinoma of breast diagnosed by PET/CT: an unusual presentation. D'souza MM; Sharma R; Tripathi M; Saw SK; Anand A; Singh D; Mondal A Clin Nucl Med; 2010 Oct; 35(10):820-3. PubMed ID: 20838299 [TBL] [Abstract][Full Text] [Related]
24. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT. Kitajima K; Murakami K; Yamasaki E; Domeki Y; Kaji Y; Morita S; Suganuma N; Sugimura K Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):362-72. PubMed ID: 18931841 [TBL] [Abstract][Full Text] [Related]
25. Carcinosarcoma of the uterine corpus on 18F-FDG PET/CT in a postmenopausal woman with elevated AFP. Chen F; Yu C; You X; Mi B; Wan W Clin Nucl Med; 2014 Sep; 39(9):803-5. PubMed ID: 24152629 [TBL] [Abstract][Full Text] [Related]
26. Is It Time to Introduce PET/CT in Rectal Cancer Guidelines? Maffione AM; Montesi G; Caroli P; Colletti PM; Rubello D; Matteucci F Clin Nucl Med; 2020 Aug; 45(8):611-617. PubMed ID: 32558716 [TBL] [Abstract][Full Text] [Related]
27. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796 [TBL] [Abstract][Full Text] [Related]
28. Individualized threshold for tumor segmentation in 18F-FDG PET/CT imaging: The key for response evaluation of neoadjuvant chemoradiation therapy in patients with rectal cancer? Fagundes TC; Mafra A; Silva RG; Castro ACG; Silva LC; Aguiar PT; Silva JA; P Junior E; Machado AM; Mamede M Rev Assoc Med Bras (1992); 2018 Feb; 64(2):119-126. PubMed ID: 29641665 [TBL] [Abstract][Full Text] [Related]
29. 18F-FDG PET/CT Demonstrating Chorioadenoma Destruens After Evacuation of Complete Hydatidiform Mole. Sharma P Clin Nucl Med; 2017 Oct; 42(10):766-767. PubMed ID: 28759528 [TBL] [Abstract][Full Text] [Related]
30. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Horowitz NS; Dehdashti F; Herzog TJ; Rader JS; Powell MA; Gibb RK; Grigsby PW; Siegel BA; Mutch DG Gynecol Oncol; 2004 Dec; 95(3):546-51. PubMed ID: 15581961 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of FDG-PET for detecting lymph node metastasis in uterine corpus cancer. Klar M; Meyer PT; Hancke K; Brink I; Orlowska-Volk M; Gitsch G; Denschlag D Anticancer Res; 2010 Sep; 30(9):3787-90. PubMed ID: 20944170 [TBL] [Abstract][Full Text] [Related]
32. A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT. Yin H; Hu Y; Xiu Y; Luo R; Shi H Clin Nucl Med; 2019 Jul; 44(7):e425-e427. PubMed ID: 30985410 [TBL] [Abstract][Full Text] [Related]
34. Adenocarcinoma of the Cervix Uteri and Endometrium Combined With the Kartagener Syndrome on FDG PET/CT. Zhang Y; Chen Y; Huang Z; Zhou F Clin Nucl Med; 2015 Nov; 40(11):922-3. PubMed ID: 26284775 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis of Primary Intestinal-Type Adenocarcinoma in the Nasal Cavity by 18F-FDG PET/CT. Fu Z; Zhang J; Liu M; Li Z; Li Q Clin Nucl Med; 2016 Nov; 41(11):888-889. PubMed ID: 27607163 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA. Gade M; Kubik M; Fisker RV; Thorlacius-Ussing O; Petersen LJ Cancer Imaging; 2015 Aug; 15(1):11. PubMed ID: 26263901 [TBL] [Abstract][Full Text] [Related]
37. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219 [TBL] [Abstract][Full Text] [Related]
38. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
39. Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging. Sharma P; Kumar R; Singh H; Jeph S; Sharma JB; Jain SK; Sharma DN; Bal C; Malhotra A Nucl Med Commun; 2012 Feb; 33(2):185-90. PubMed ID: 22107993 [TBL] [Abstract][Full Text] [Related]